News & Updates
Filter by Specialty:
Relugolix leads to rapid, sustained profound testosterone suppression in advanced PCa
Use of the oral non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix led to faster and greater sustained profound testosterone suppression than leuprolide in men with advanced prostate cancer, according to results of the phase III HERO study presented at EAU 2022.
Relugolix leads to rapid, sustained profound testosterone suppression in advanced PCa
25 Aug 2022
ASCL1 a potential therapeutic target for treating Cushing’s disease
A recent study attempting to understand the pathogenesis of Cushing’s disease (CD) suggests the potential of achaete-scute complex homolog 1 (ASCL1), a pioneer transcription factor, as a therapeutic target for the treatment of CD.
ASCL1 a potential therapeutic target for treating Cushing’s disease
20 Aug 2022
Good cholesterol tied to better memory, executive function in older diabetic patients
High levels of high-density lipoprotein (HDL) cholesterol appear to correlate with better changes in memory and executive function in older adults with diabetes mellitus, according to a recent China study.
Good cholesterol tied to better memory, executive function in older diabetic patients
19 Aug 2022
Poor mental health raises risk of incident T2D
People with worse overall psychological wellbeing are at significantly higher risk of developing type 2 diabetes (T2D) in a dose‒response manner irrespective of their genetic predisposition, suggest the results of a recent study.
Poor mental health raises risk of incident T2D
18 Aug 2022
Counseling intervention helps avert weight gain in midlife women
Women who are trying to prevent obesity during midlife may benefit from counseling interventions, which a recent study has shown to result in modest differences in weight change without causing any significant harm.